Premphase

Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.🇺🇸 United States

FDA Page

Effective Date: Apr 28, 2026
Approval ID: fd0c0836-5d23-2183-da81-9dc7f4287052
Products: 5 registered
Version: 39

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use PREMPRO/PREMPHASE safely and effectively. See full prescribing information for PREMPRO/PREMPHASE. PREMPRO (conjugated estrogens/medroxyprogesterone acetate tablets) PREMPHASE (conjugated estrogens plus medroxyprogesterone acetate tablets)Initial U.S. Approval: 1995

Quick Stats

Total Products5

Labelers2

Label Sections49

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.